A Single Ketamine Dose Could Change How We Treat Fentanyl Addiction
A new study from AltaPointe Health now shows that an ultra low dose of ketamine may treat fentanyl addiction.
Read More
A Single Dose of Ketamine May Ease Chronic Fatigue, New Study Finds
The study found a single low dose of ketamine reduced fatigue scores by 21% within three days. The effect peaked at 24 hours, when fatigue dropped by nearly 39%.
Read More
Ketamine’s Psychedelic Effects May Not Be Why It Treats Alcohol Addiction
A new study from King's College London and the University of Exeter is challenging a popular assumption in ketamine therapy.
Read More
New Study Reveals Why Ketamine Therapy Works — And It Starts With Your Patient’s Metabolism
Without the metabolite 2R6R, ketamine alone failed to produce the lasting brain plasticity tied to its therapeutic effects.
Read More
Attorney General Misses Deadline to Streamline Research on Psychedelics
The Department of Justice failed to meet a January 16 deadline to publish new rules simplifying Schedule I research.
Read More
GLP-1 Providers Can Now Drive New Revenue Streams Through Diagnostic Bundling
The compounded GLP-1 market has become fiercely competitive. Most clinics compete on price and speed. Mindful Labs wants to change that equation entirely. Key Takeaway Details Revenue per patient $40 per consult (three times per year) For every 100 patients You earn $12,000 annually (this is in incremental to medication or visit revenues) Operational lift […]
Read More
Texas Medical Board Proposes Sweeping New Rules for Ketamine Clinics
This proposal introduces mandatory registration for clinics and establishes strict standards for patient monitoring.
Read More
Why Timing Matters: The Science Behind Scheduling Psychotherapy After Ketamine
New insights: Should psychotherapy happen during the ketamine session, immediately after, or the following day?
Read More
Congressional Psychedelics Report Card: Who Supports and Opposes Legalization
Knowing which members of Congress will advance or block psychedelic medicine helps advocates know where to focus their energy.
Read More
Bipartisan Bill Would Let Doctors Administer MDMA and Psilocybin to Seriously Ill Patients
The Freedom to Heal Act would allow doctors to legally administer Schedule I drugs like MDMA and psilocybin to very ill patients.
Read More